When it comes to protection against flu and COVID, vaccines are necessary to tackle the latest strains of each. Here's what you need to know.
Doulas are non-medical aides who provide information and support to parents before, during, and shortly after the birth of their babies. Supporters say the state should make doulas in NC more affordable.
These two campaigns have vast differences in their policies to address climate change, and I believe the Harris-Walz campaign is taking steps to address our climate crisis in ways that will benefit North Carolina. Vice President Harris was the deciding vote on the Inflation Reduction Act, which included the largest investment to combat climate change in American history.
Vice President Kamala Harris announced lowered child care costs for working families in North Carolina, building on prior federal funding for child care programs and promising more.
As a presidential candidate, Kamala Harris is building on previous efforts to improve health care in North Carolina.
Vice President Kamala Harris announces lowered child care costs for working families in North Carolina, building on prior federal funding for child care programs and promising more.
The White House estimates that these new prices will lead to around $6 billion in savings for the Medicare program in 2026. The new prices will be anywhere from 38% to 79% lower than the drugs’ list prices last year, saving seniors on Medicare an estimated $1.5 billion in out-of-pocket costs in 2026 alone.
As a result of the Biden-Harris administration’s Inflation Reduction Act, Medicare recipients now pay no more than $35 a month for insulin. Carrol Olinger was panicking. It was 2022, and the retired Fayetteville teacher — disabled and between jobs —...
The Biden-Harris administration provides North Carolina nursing schools with much-needed funding, boosting the nursing workforce. North Carolina faces a nursing shortage, with a predicted deficit of about 17,000 nurses by 2033. But there’s good news. Thanks to...
AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline all agreed to cap the price of asthma inhalers earlier this year following an investigation by a Democratic-led Senate Committee.
